• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锌指转录因子 Slug 有助于慢性髓性白血病细胞的生存优势。

Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells.

机构信息

Department of Hematology and Oncology Lorenzo e Ariosto Seràgnoli, University of Bologna-Medical School, Via Massarenti 9, 40138-Bologna, Italy.

出版信息

Cell Signal. 2010 Aug;22(8):1247-53. doi: 10.1016/j.cellsig.2010.04.002. Epub 2010 Apr 11.

DOI:10.1016/j.cellsig.2010.04.002
PMID:20388540
Abstract

Slug, a Snail-related zinc-finger transcription factor implicated in the increased motility of mesenchymal cells during embryonic development and progression of cancer cells towards an invasive phenotype, plays a specific and critical role in the pathogenesis of Bcr-Abl-associated leukemias. Here we report that Slug over-expression associated with Bcr-Abl is conditional upon the tyrosine kinase (TK) activity of 210 fusion protein. Slug over-expression is driven by transcriptional events eventually integrated by post-transcriptional mechanisms leading to protein stabilization and is at least partly regulated by the ERK1/2 mitogen-activated protein kinase (MAPK). It contributes to apoptosis resistance of leukemic progenitors through the repression of pro-apoptotic Puma. Moreover, Slug is a component of leukemic progenitor resistance to imatinib mesylate (IM) driven by Bcr-Abl point mutations and, in particular, by T315I. Slug over-expression associated with p210 Bcr-Abl TK either in the wild type (wt) or mutated conformation results in a significant reduction of E-cadherin, the substrate of Beta catenin at cell membranes. In conclusion, our results suggest that Slug has a central role in a complex network involved in prolonged survival and IM resistance of CML progenitors.

摘要

Slug 是一种与蜗牛相关的锌指转录因子,在胚胎发育过程中间质细胞的迁移和癌细胞向侵袭表型的进展中发挥作用,在 Bcr-Abl 相关白血病的发病机制中发挥特定而关键的作用。在这里,我们报告 Slug 的过度表达与 Bcr-Abl 相关,这取决于 210 融合蛋白的酪氨酸激酶 (TK) 活性。Slug 的过度表达是由转录事件驱动的,最终通过转录后机制进行整合,导致蛋白质稳定,并至少部分受到 ERK1/2 丝裂原活化蛋白激酶 (MAPK) 的调节。它通过抑制促凋亡的 Puma 来促进白血病祖细胞的抗凋亡作用。此外,Slug 是由 Bcr-Abl 点突变驱动的白血病祖细胞对伊马替尼 (IM) 耐药的组成部分,特别是 T315I。与野生型 (wt) 或突变构象的 p210 Bcr-Abl TK 相关的 Slug 过度表达会导致细胞表面的 E-cadherin(β-catenin 的底物)显著减少。总之,我们的结果表明,Slug 在涉及 CML 祖细胞长期存活和对 IM 耐药的复杂网络中发挥核心作用。

相似文献

1
Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells.锌指转录因子 Slug 有助于慢性髓性白血病细胞的生存优势。
Cell Signal. 2010 Aug;22(8):1247-53. doi: 10.1016/j.cellsig.2010.04.002. Epub 2010 Apr 11.
2
Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein.在两个表达p210 Bcr/Abl蛋白的白血病细胞系中,与对伊马替尼(STI571)产生耐药性相关的变化。
Cancer. 2004 Apr 1;100(7):1459-71. doi: 10.1002/cncr.20131.
3
Cleavage of BCR-ABL transcripts at the T315I point mutation by DNAzyme promotes apoptotic cell death in imatinib-resistant BCR-ABL leukemic cells.DNA 酶在 T315I 点突变处切割 BCR-ABL 转录本,促进伊马替尼耐药 BCR-ABL 白血病细胞的凋亡性细胞死亡。
Leukemia. 2013 Aug;27(8):1650-8. doi: 10.1038/leu.2013.60. Epub 2013 Feb 25.
4
ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.由BCR-ABL调节的凋亡微小RNA表达与慢性粒细胞白血病进展及伊马替尼耐药相关。
Blood Cells Mol Dis. 2014 Jun-Aug;53(1-2):47-55. doi: 10.1016/j.bcmd.2014.02.008. Epub 2014 Mar 11.
5
HS-438, a new inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia.HS-438,一种新型伊马替尼耐药 BCR-ABL T315I 突变慢性髓性白血病抑制剂。
Cancer Lett. 2014 Jun 28;348(1-2):50-60. doi: 10.1016/j.canlet.2014.03.012. Epub 2014 Mar 18.
6
Synergistic interactions between DMAG and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylate.二甲氨基胍(DMAG)与丝裂原活化蛋白激酶激酶1/2抑制剂在对甲磺酸伊马替尼敏感和耐药的Bcr/abl+白血病细胞中的协同相互作用。
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2239-47. doi: 10.1158/1078-0432.CCR-05-2282.
7
A new nonpeptidic inhibitor of 14-3-3 induces apoptotic cell death in chronic myeloid leukemia sensitive or resistant to imatinib.一种新型非肽 14-3-3 抑制剂诱导对伊马替尼敏感或耐药的慢性髓系白血病细胞凋亡。
J Pharmacol Exp Ther. 2011 Mar;336(3):596-604. doi: 10.1124/jpet.110.172536. Epub 2010 Nov 1.
8
Chk2 drives late G1/early S phase arrest of clonal myeloid progenitors expressing the p210 BCR-ABL tyrosine kinase in response to STI571.Chk2促使表达p210 BCR-ABL酪氨酸激酶的克隆性髓系祖细胞在G1晚期/S期早期停滞,以响应STI571。
Hematol J. 2004;5(2):168-77. doi: 10.1038/sj.thj.6200365.
9
The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl+ human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation.多激酶抑制剂索拉非尼可诱导对甲磺酸伊马替尼高度耐药的bcr/abl+人白血病细胞凋亡,这与信号转导和转录激活因子5的抑制以及髓样细胞白血病-1的下调有关。
Mol Pharmacol. 2007 Sep;72(3):788-95. doi: 10.1124/mol.106.033308. Epub 2007 Jun 26.
10
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.FTY720,一种治疗急变期慢性粒细胞白血病和费城染色体阳性急性淋巴细胞白血病的新选择。
J Clin Invest. 2007 Sep;117(9):2408-21. doi: 10.1172/JCI31095.

引用本文的文献

1
Exploring the Role of Epithelial-Mesenchymal Transcriptional Factors Involved in Hematological Malignancy and Solid Tumors: A Systematic Review.探索上皮-间质转录因子在血液系统恶性肿瘤和实体瘤中的作用:一项系统综述
Cancers (Basel). 2025 Feb 5;17(3):529. doi: 10.3390/cancers17030529.
2
Cisplatin‑resistant germ cell tumor models: An exploration of the epithelial‑mesenchymal transition regulator .顺铂耐药生殖细胞肿瘤模型:上皮-间充质转化调控因子的探索
Mol Med Rep. 2024 Dec;30(6). doi: 10.3892/mmr.2024.13352. Epub 2024 Oct 11.
3
Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response.
利用 EMT 功能克服癌症耐药性:一个调节转移的因子决定化疗反应。
Cancer Metastasis Rev. 2024 Mar;43(1):457-479. doi: 10.1007/s10555-023-10162-7. Epub 2024 Jan 16.
4
An "unexpected" role for EMT transcription factors in hematological development and malignancy.EMT 转录因子在血液系统发育和恶性肿瘤中的“意外”作用。
Front Immunol. 2023 Aug 3;14:1207360. doi: 10.3389/fimmu.2023.1207360. eCollection 2023.
5
Effect of modulation of epithelial-mesenchymal transition regulators Snail1 and Snail2 on cancer cell radiosensitivity by targeting of the cell cycle, cell apoptosis and cell migration/invasion.通过靶向细胞周期、细胞凋亡和细胞迁移/侵袭来调节上皮-间质转化调节因子Snail1和Snail2对癌细胞放射敏感性的影响。
Oncol Lett. 2019 Jan;17(1):23-30. doi: 10.3892/ol.2018.9636. Epub 2018 Oct 29.
6
Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?上皮-间充质转化诱导转录因子:攻克癌症化疗耐药性的新靶点?
Oncogene. 2018 Nov;37(48):6195-6211. doi: 10.1038/s41388-018-0378-x. Epub 2018 Jul 12.
7
The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome.《海妖觉醒:诱导 EMT 作为肿瘤侵袭和不良预后的驱动因素》。
Clin Exp Metastasis. 2018 Apr;35(4):285-308. doi: 10.1007/s10585-018-9906-x. Epub 2018 Jun 8.
8
Emerging roles of epithelial-mesenchymal transition in hematological malignancies.上皮-间充质转化在血液恶性肿瘤中的新作用。
J Biomed Sci. 2018 Apr 23;25(1):37. doi: 10.1186/s12929-018-0440-6.
9
Ectopic Expression of Snail and Twist in Ph+ Leukemia Cells Upregulates CD44 Expression and Alters Their Differentiation Potential.Snail和Twist在Ph+白血病细胞中的异位表达上调CD44表达并改变其分化潜能。
J Cancer. 2017 Oct 23;8(19):3952-3968. doi: 10.7150/jca.19633. eCollection 2017.
10
SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour.SLUG转录因子:胃肠道间质瘤中的一种促生存和预后因子。
Br J Cancer. 2017 Apr 25;116(9):1195-1202. doi: 10.1038/bjc.2017.82. Epub 2017 Mar 23.